Ritu Salani

Title(s)Professor, Obstetrics and Gynecology
SchoolMedicine
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. A non-comparative, randomized, phase II trial of atezolizumab or atezolizumab plus tiragolumab for programmed death-ligand 1-positive recurrent cervical cancer (SKYSCRAPER-04). Int J Gynecol Cancer. 2024 Jun 10. Salani R, McCormack M, Kim YM, Ghamande S, Hall SL, Lorusso D, Barraclough L, Gilbert L, Guzman Ramirez A, Lu CH, Sabatier R, Colombo N, Hu Y, Krishnan V, Molinero L, Feng Y, Kim N, Castro M, Lin YG, Monk BJ. PMID: 38858106.
      View in: PubMed   Mentions:    Fields:    
    2. Vulvar Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2024 03; 22(2):117-135. Abu-Rustum NR, Yashar CM, Arend R, Barber E, Bradley K, Brooks R, Campos SM, Chino J, Chon HS, Crispens MA, Damast S, Fisher CM, Frederick P, Gaffney DK, Gaillard S, Giuntoli R, Glaser S, Holmes J, Howitt BE, Kendra K, Lea J, Lee N, Mantia-Smaldone G, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Podoll M, Rodabaugh K, Salani R, Schorge J, Siedel J, Sisodia R, Soliman P, Ueda S, Urban R, Wethington SL, Wyse E, Zanotti K, McMillian N, Espinosa S. PMID: 38503056.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    3. Cytochrome P450 inhibitor/inducer treatment patterns among patients in the United States with advanced ovarian cancer who were prescribed or were eligible for poly(adenosine diphosphate [ADP]-ribose) polymerase inhibitors in the first-line maintenance setting. Gynecol Oncol Rep. 2024 Feb; 51:101332. Rimel BJ, Chase DM, Perhanidis J, Ghazarian AA, Du EX, Wang T, Song J, Golembesky AK, Hurteau JA, Kalilani L, Salani R, Monk BJ. PMID: 38362364; PMCID: PMC10867570.
      View in: PubMed   Mentions:
    4. Changes in prospectively collected patient-reported outcomes among women with incident endometrial cancer. J Cancer Surviv. 2024 Jan 24. Sinnott JA, Torkashvand E, Meade CE, Salani R, Vetter MH, Hall B, Skolnick R, Bixel KL, Cohn DE, Cosgrove CM, Copeland LJ, Hebert C, Felix AS. PMID: 38265703.
      View in: PubMed   Mentions:    Fields:    
    5. Information needs during cancer care: Qualitative research with locally advanced cervical cancer patients in Brazil, China, Germany, & the US. Gynecol Oncol Rep. 2024 Feb; 51:101321. Szamreta EA, Mulvihill E, Aguinaga K, Amos K, Zannit H, Salani R. PMID: 38273935; PMCID: PMC10809109.
      View in: PubMed   Mentions:
    6. Underrepresentation of racial and ethnic minority groups in gynecologic oncology: An analysis of over 250 trials. Gynecol Oncol. 2024 Feb; 181:1-7. Richardson MT, Barry D, Steinberg JR, Thirunavu V, Strom DE, Holder K, Zhang N, Turner BE, Magnani CJ, Weeks BT, Young AMP, Lu CF, Wolgemuth TR, Laasiri N, Squires NA, Anderson JN, Karlan BY, Chan JK, Kapp DS, Roque DR, Salani R. PMID: 38096673.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Lunchbox trial: A randomized phase III trial of cisplatin and irradiation followed by carboplatin and paclitaxel versus sandwich therapy of carboplatin and paclitaxel followed by irradiation then carboplatin and paclitaxel for advanced endometrial carcinoma. Gynecol Oncol. 2024 Jan; 180:63-69. Barlin JN, Mahar B, Ata A, Cormier B, Michelin D, Salani R, Backes F, Levinson K, Cantrell LA, Weinberg L, Wagreich A, Savage D, Gasson C, Denniston K, Martin J, McElrath T, Timmins PF. PMID: 38052110.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    8. NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024. J Natl Compr Canc Netw. 2023 12; 21(12):1224-1233. Abu-Rustum NR, Yashar CM, Arend R, Barber E, Bradley K, Brooks R, Campos SM, Chino J, Chon HS, Crispens MA, Damast S, Fisher CM, Frederick P, Gaffney DK, Gaillard S, Giuntoli R, Glaser S, Holmes J, Howitt BE, Lea J, Mantia-Smaldone G, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Podoll M, Rodabaugh K, Salani R, Schorge J, Siedel J, Sisodia R, Soliman P, Ueda S, Urban R, Wyse E, McMillian NR, Aggarwal S, Espinosa S. PMID: 38081139.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    9. A review of the state of cervical cancer: updates from prevention to recurrent disease. Curr Opin Obstet Gynecol. 2024 02 01; 36(1):28-33. Crafton SM, Venkat PS, Salani R. PMID: 37873756.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    10. TP53 mutation and abnormal p53 expression in endometrial cancer: Associations with race and outcomes. Gynecol Oncol. 2023 Nov; 178:44-53. Whelan K, Dillon M, Strickland KC, Pothuri B, Bae-Jump V, Borden LE, Thaker PH, Haight P, Arend RC, Ko E, Jackson AL, Corr BR, Ayoola-Adeola M, Wright JD, Podwika S, Smitherman C, Thomas S, Lightfoot M, Newton M, Washington C, Mullen M, Cosgrove C, Harsono AAH, Powell K, Herzog TJ, Salani R, Alvarez Secord A. PMID: 37748270.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    11. Pathologic response to neoadjuvant chemotherapy in ovarian cancer and its association with outcome: A surrogate marker of survival. Gynecol Oncol. 2023 Oct; 177:173-179. Marsh LA, Kim TH, Zhang M, Kubalanza K, Treece CL, Chase D, Memarzadeh S, Salani R, Karlan B, Rao J, Konecny GE. PMID: 37716223.
      View in: PubMed   Mentions:    Fields:    
    12. Assessment of the feasibility of same-day discharge following minimally invasive hysterectomy in the elderly population. Gynecol Oncol Rep. 2023 Aug; 48:101227. Haight PJ, Piver RN, Barrington DA, Baek J, Graves SM, Ardizzone M, Akinduro JA, Busho AC, Fadoju D, Pandit R, Stephens R, Strowder LM, Tadepalli S, VanNoy B, Sriram B, McLaughlin EM, Ds Lightfoot M, Chambers LM, Bixel KL, Cohn DE, Cosgrove CM, O'Malley D, Salani R, Backes FJ, I Nagel C. PMID: 37415961; PMCID: PMC10320489.
      View in: PubMed   Mentions:
    13. Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2023 02; 21(2):181-209. Abu-Rustum N, Yashar C, Arend R, Barber E, Bradley K, Brooks R, Campos SM, Chino J, Chon HS, Chu C, Crispens MA, Damast S, Fisher CM, Frederick P, Gaffney DK, Giuntoli R, Han E, Holmes J, Howitt BE, Lea J, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Podoll M, Salani R, Schorge J, Siedel J, Sisodia R, Soliman P, Ueda S, Urban R, Wethington SL, Wyse E, Zanotti K, McMillian NR, Aggarwal S. PMID: 36791750.
      View in: PubMed   Mentions: 72     Fields:    Translation:Humans
    14. Safety and feasibility of same-day discharge following minimally invasive hysterectomy in the morbidly obese patient population. Gynecol Oncol. 2023 03; 170:203-209. Haight PJ, Barrington DA, Graves SM, Piver RN, Baek J, Ardizzone M, Akinduro JA, Busho AC, Fadoju D, Pandit R, Stephens R, Strowder LM, Tadepalli S, VanNoy B, Sriram B, McLaughlin EM, Lightfoot MDS, Bixel KL, Cohn DE, Cosgrove CM, O'Malley D, Salani R, Nagel CI, Backes FJ. PMID: 36709661.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    15. The increasing incidence of stage IV cervical cancer in the USA: what factors are related? Int J Gynecol Cancer. 2022 08 18. Francoeur AA, Liao CI, Caesar MA, Chan A, Kapp DS, Cohen JG, Salani R, Chan JK. PMID: 35981903.
      View in: PubMed   Mentions: 12     Fields:    
    16. Less is more: clinical utility of postoperative laboratory testing following minimally invasive hysterectomy for endometrial cancer. Am J Obstet Gynecol. 2022 Aug 02. Lightfoot MDS, Felix AS, Calo CA, Hosmer-Quint JT, Taylor KL, Brown MB, Salani R, Copeland LJ, O'Malley DM, Bixel KL, Cohn DE, Fowler JM, Backes FJ, Cosgrove CM. PMID: 35931127.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    17. Frailty is independently associated with worse outcomes and increased resource utilization following endometrial cancer surgery. Int J Gynecol Cancer. 2022 Jun 20. Nakhla M, Eakin CM, Mandelbaum A, Karlan B, Benharash P, Salani R, Cohen JG. PMID: 35725031; PMCID: PMC9763544.
      View in: PubMed   Mentions: 1     Fields:    
    18. Rapidly progressing vulvar soft tissue infection as a result of severe hypogammaglobulinemia following CAR T-cell therapy. Gynecol Oncol Rep. 2022 Aug; 42:101016. Cotangco K, Manrriquez EN, Salani R. PMID: 35711731; PMCID: PMC9194578.
      View in: PubMed   Mentions:
    19. Sentinel lymph node mapping for endometrial cancer: Opportunity for medical waste reform. Gynecol Oncol. 2022 07; 166(1):162-164. Marsh LA, Aviki EM, Wright JD, Chen L, Abu-Rustum N, Salani R. PMID: 35597685.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    20. The association of obesity with type I uterine cancer-is this an oversimplification? Am J Obstet Gynecol. 2022 09; 227(3):538-539. Eakin CM, Liao CI, Salani R, Cohen JG, Kapp DS, Chan JK. PMID: 35562051; PMCID: PMC9420798.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    21. Surgical Science-Simbionix Robotic Hysterectomy Simulator: Validating a New Tool. J Minim Invasive Gynecol. 2022 06; 29(6):759-766. Cope AG, Lazaro-Weiss JJ, Willborg BE, Lindstrom ED, Mara KC, Destephano CC, Vetter MH, Glaser GE, Langstraat CL, Chen AH, Martino MA, Dinh TA, Salani R, Green IC. PMID: 35123040.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    22. Precision medicine for cervical cancer. Curr Opin Obstet Gynecol. 2022 02 01; 34(1):1-5. Manrriquez EN, Zakhour M, Salani R. PMID: 34596094.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    23. Implicit biases in healthcare: implications and future directions for gynecologic oncology. Am J Obstet Gynecol. 2022 07; 227(1):1-9. Torres TK, Chase DM, Salani R, Hamann HA, Stone J. PMID: 35026128.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    24. Who will be readmitted? Evaluation of the laparoscopic hysterectomy readmission score in a gynecologic oncology population undergoing robotic-assisted hysterectomy. Gynecol Oncol. 2022 03; 164(3):628-638. Lightfoot MDS, Felix AS, Bishop EE, Henderson AP, Vetter MH, Salani R, O'Mallley DM, Bixel KL, Cohn DE, Fowler JM, Backes FJ. PMID: 34969534.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    25. The role of high-risk HPV testing in cervical cancer surveillance. Gynecol Oncol. 2022 02; 164(2):357-361. Aryasomayajula C, Chanana A, Tandel M, Kwan L, Cohen JG, Lai TS, Salani R, Zakhour M. PMID: 34836678.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    26. Patient-reported outcome changes at the end of life in recurrent platinum-resistant ovarian cancer: An NRG oncology/GOG study. Gynecol Oncol. 2021 11; 163(2):392-397. Wenzel L, Huang HQ, Cella D, McKinney CO, Zevon MA, LaChance JA, Walker JL, Salani R, Modesitt SC, Morris RT, Bradley WH, Boente MP, von Gruenigen VE. PMID: 34548162; PMCID: PMC8805698.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    27. Changing paradigms in intermediate-risk cervical cancer: Sedlis revisited. Gynecol Oncol. 2021 09; 162(3):527-528. Venkat P, Salani R. PMID: 34454679.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    28. NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021. J Natl Compr Canc Netw. 2021 08 01; 19(8):888-895. Abu-Rustum NR, Yashar CM, Bradley K, Campos SM, Chino J, Chon HS, Chu C, Cohn D, Crispens MA, Damast S, Diver E, Fisher CM, Frederick P, Gaffney DK, George S, Giuntoli R, Han E, Howitt B, Huh WK, Lea J, Mariani A, Mutch D, Nekhlyudov L, Podoll M, Remmenga SW, Reynolds RK, Salani R, Sisodia R, Soliman P, Tanner E, Ueda S, Urban R, Wethington SL, Wyse E, Zanotti K, McMillian NR, Motter AD. PMID: 34416706.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    29. Phase I evaluation of lenvatinib and weekly paclitaxel in patients with recurrent endometrial, ovarian, fallopian tube, or primary peritoneal Cancer. Gynecol Oncol. 2021 09; 162(3):619-625. Backes FJ, Wei L, Chen M, Hill K, Dzwigalski K, Poi M, Phelps M, Salani R, Copeland LJ, Fowler JM, Cohn DE, Bixel K, Cosgrove C, Hays J, O'Malley D. PMID: 34272090.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    30. The American Society of Clinical Oncology 2021 annual (virtual) meeting: A review and summary of selected abstracts. Gynecol Oncol. 2021 08; 162(2):245-248. Salani R, Liu JF. PMID: 34210516.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    31. The long game: Evolution of clinical decision making throughout residency and fellowship. Am J Surg. 2022 Feb; 223(2):266-272. Woelfel IA, Smith BQ, Salani R, Harzman AE, Cochran AL, Chen XP. PMID: 33752873; PMCID: PMC9045150.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    32. Unwittingly biased: A note to gynecologic cancer providers. Gynecol Oncol. 2021 03; 160(3):646-648. Chase DM, Salani R, Farley J, Torres T, Stone J. PMID: 33485640.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    33. Pilot study of fractional CO2 laser therapy for genitourinary syndrome of menopause in gynecologic cancer survivors. Maturitas. 2021 Feb; 144:37-44. Quick AM, Dockter T, Le-Rademacher J, Salani R, Hudson C, Hundley A, Terstriep S, Streicher L, Faubion S, Loprinzi CL, Coleman JS, Wang KC, Lustberg M. PMID: 33358206; PMCID: PMC7773136.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    34. Moving Forward in Cervical Cancer: Enhancing Susceptibility to DNA Repair Inhibition and Damage, an NCI Clinical Trials Planning Meeting Report. J Natl Cancer Inst. 2020 11 01; 112(11):1081-1088. Harkenrider MM, Markham MJ, Dizon DS, Jhingran A, Salani R, Serour RK, Lynn J, Kohn EC. PMID: 32219419; PMCID: PMC7669233.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    35. An ecological evaluation of the increasing incidence of endometrial cancer and the obesity epidemic. Am J Obstet Gynecol. 2021 05; 224(5):506.e1-506.e8. Smrz SA, Calo C, Fisher JL, Salani R. PMID: 33127429.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansPHPublic Health
    36. Double somatic mismatch repair gene pathogenic variants as common as Lynch syndrome among endometrial cancer patients. Gynecol Oncol. 2021 01; 160(1):161-168. Hampel H, Pearlman R, de la Chapelle A, Pritchard CC, Zhao W, Jones D, Yilmaz A, Chen W, Frankel WL, Suarez AA, Cosgrove C, Backes F, Copeland L, Fowler J, O'Malley D, Salani R, McElroy JP, Stanich PP, Goodfellow P, Cohn DE. PMID: 33393477; PMCID: PMC7783191.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    37. Feasibility of implementing a text-based symptom-monitoring program of endometrial, ovarian, and breast cancer patients during treatment. Qual Life Res. 2021 Nov; 30(11):3241-3254. Naughton MJ, Salani R, Peng J, Lustberg M, DeGraffinreid C, Moon J, Loyan H, Beverly Hery CM, Paskett ED. PMID: 33052514; PMCID: PMC8528739.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    38. Circulating Tumor Cells In Advanced Cervical Cancer: NRG Oncology-Gynecologic Oncology Group Study 240 (NCT 00803062). Mol Cancer Ther. 2020 11; 19(11):2363-2370. Tewari KS, Sill MW, Monk BJ, Penson RT, Moore DH, Lankes HA, Ramondetta LM, Landrum LM, Randall LM, Oaknin A, Leitao MM, Eisenhauer EL, DiSilvestro P, Van Le L, Pearl ML, Burke JJ, Salani R, Richardson DL, Michael HE, Kindelberger DW, Birrer MJ. PMID: 32847980; PMCID: PMC7907274.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCellsCTClinical Trials
    39. Meeting report from the 2020 Annual (virtual) Meeting of the American Society of Clinical Oncology. Gynecol Oncol. 2020 10; 159(1):13-16. Salani R, Liu JF. PMID: 32771275; PMCID: PMC7405821.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    40. Practice patterns in post-treatment surveillance in patients with primary epithelial ovarian cancer. Int J Gynecol Cancer. 2021 06; 31(6):888-892. DeMari J, Vetter MH, Chandra S, Hays JL, Salani R. PMID: 32759182.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    41. Resident Self-Entrustment and Expectations of Autonomy: OB > GYN? J Surg Educ. 2021 Jan-Feb; 78(1):275-281. Smith BQ, Woelfel I, Salani R, Harzman A, Chen X. PMID: 32753260.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    42. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants. Genet Med. 2020 10; 22(10):1653-1666. Barnes DR, Rookus MA, McGuffog L, Leslie G, Mooij TM, Dennis J, Mavaddat N, Adlard J, Ahmed M, Aittomäki K, Andrieu N, Andrulis IL, Arnold N, Arun BK, Azzollini J, Balmaña J, Barkardottir RB, Barrowdale D, Benitez J, Berthet P, Bialkowska K, Blanco AM, Blok MJ, Bonanni B, Boonen SE, Borg Å, Bozsik A, Bradbury AR, Brennan P, Brewer C, Brunet J, Buys SS, Caldés T, Caligo MA, Campbell I, Christensen LL, Chung WK, Claes KBM, Colas C, GEMO Study Collaborators, EMBRACE Collaborators, Collonge-Rame MA, Cook J, Daly MB, Davidson R, de la Hoya M, de Putter R, Delnatte C, Devilee P, Diez O, Ding YC, Domchek SM, Dorfling CM, Dumont M, Eeles R, Ejlertsen B, Engel C, Evans DG, Faivre L, Foretova L, Fostira F, Friedlander M, Friedman E, Frost D, Ganz PA, Garber J, Gehrig A, Gerdes AM, Gesta P, Giraud S, Glendon G, Godwin AK, Goldgar DE, González-Neira A, Greene MH, Gschwantler-Kaulich D, Hahnen E, Hamann U, Hanson H, Hentschel J, Hogervorst FBL, Hooning MJ, Horvath J, Hu C, Hulick PJ, Imyanitov EN, kConFab Investigators, HEBON Investigators, GENEPSO Investigators, Isaacs C, Izatt L, Izquierdo A, Jakubowska A, James PA, Janavicius R, John EM, Joseph V, Karlan BY, Kast K, Koudijs M, Kruse TA, Kwong A, Laitman Y, Lasset C, Lazaro C, Lester J, Lesueur F, Liljegren A, Loud JT, Lubinski J, Mai PL, Manoukian S, Mari V, Mebirouk N, Meijers-Heijboer HEJ, Meindl A, Mensenkamp AR, Miller A, Montagna M, Mouret-Fourme E, Mukherjee S, Mulligan AM, Nathanson KL, Neuhausen SL, Nevanlinna H, Niederacher D, Nielsen FC, Nikitina-Zake L, Noguès C, Olah E, Olopade OI, Ong KR, O'Shaughnessy-Kirwan A, Osorio A, Ott CE, Papi L, Park SK, Parsons MT, Pedersen IS, Peissel B, Peixoto A, Peterlongo P, Pfeiler G, Phillips KA, Prajzendanc K, Pujana MA, Radice P, Ramser J, Ramus SJ, Rantala J, Rennert G, Risch HA, Robson M, Rønlund K, Salani R, Schuster H, Senter L, Shah PD, Sharma P, Side LE, Singer CF, Slavin TP, Soucy P, Southey MC, Spurdle AB, Steinemann D, Steinsnyder Z, Stoppa-Lyonnet D, Sutter C, Tan YY, Teixeira MR, Teo SH, Thull DL, Tischkowitz M, Tognazzo S, Toland AE, Trainer AH, Tung N, van Engelen K, van Rensburg EJ, Vega A, Vierstraete J, Wagner G, Walker L, Wang-Gohrke S, Wappenschmidt B, Weitzel JN, Yadav S, Yang X, Yannoukakos D, Zimbalatti D, Offit K, Thomassen M, Couch FJ, Schmutzler RK, Simard J, Easton DF, Chenevix-Trench G, Antoniou AC, Consortium of Investigators of Modifiers of BRCA and BRCA2. PMID: 32665703; PMCID: PMC7521995.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    43. Diagnosis and Management of Adenocarcinoma in Situ: A Society of Gynecologic Oncology Evidence-Based Review and Recommendations. Obstet Gynecol. 2020 04; 135(4):869-878. Teoh D, Musa F, Salani R, Huh W, Jimenez E. PMID: 32168211; PMCID: PMC7098444.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    44. Residents' method for gaining operative autonomy. Am J Surg. 2020 10; 220(4):893-898. Woelfel I, Smith BQ, Strosberg D, Villarreal M, Harzman A, Salani R, Cochran A, Chen XP. PMID: 32248947.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    45. Guideline-concordant treatment is associated with improved survival among women with non-endometrioid endometrial cancer. Gynecol Oncol. 2020 06; 157(3):716-722. Dholakia J, Llamocca E, Quick A, Salani R, Felix AS. PMID: 32217002; PMCID: PMC7293554.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    46. The Construction of Case-Specific Resident Learning Goals. J Surg Educ. 2020 Jul - Aug; 77(4):859-865. Woelfel I, Strosberg D, Smith B, Harzman A, Salani R, Cochran A, Chen X. PMID: 32201144.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    47. Pathologic chemotherapy response score in epithelial ovarian cancer: Surgical, genetic, and survival considerations. Surg Oncol. 2020 Sep; 34:40-45. Barrington DA, Felix AS, Owda R, Suarez AA, Cohen DW, Senter L, Copeland LJ, Fowler JM, Backes FJ, Cohn DE, Bixel KL, O'Malley DM, Salani R, Cosgrove CM. PMID: 32891351.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    48. Black and Hispanic women are less likely than white women to receive guideline-concordant endometrial cancer treatment. Am J Obstet Gynecol. 2020 09; 223(3):398.e1-398.e18. Kaspers M, Llamocca E, Quick A, Dholakia J, Salani R, Felix AS. PMID: 32142825; PMCID: PMC7483220.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    49. Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group study. Int J Gynecol Cancer. 2020 05; 30(5):596-601. Chase D, Huang HQ, Monk BJ, Ramondetta LM, Penson RT, Gil K, Landrum LM, Leitao M, Oaknin A, Huh WK, Pulaski HL, Robison K, Guntupalli SR, Richardson D, Salani R, Sill MW, Wenzel LB, Tewari KS. PMID: 32114513; PMCID: PMC7780262.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    50. Intraperitoneal chemotherapy following neoadjuvant chemotherapy and optimal interval tumor reductive surgery for advanced ovarian cancer. Gynecol Oncol. 2020 03; 156(3):530-534. Bixel K, Vetter M, Davidson B, Berchuck A, Cohn D, Copeland L, Fowler JM, Havrilesky L, Lee PS, O'Malley DM, Salani R, Valea F, Alvarez Secord A, Backes F. PMID: 31937450.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    51. Meeting report from the 19th meeting of the International Gynecologic Cancer Society (IGCS) 2019: Summary of selected abstracts and meeting highlights. Gynecol Oncol. 2019 12; 155(3):389-392. Baiocchi G, Salani R. PMID: 31607399.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    52. Imaging biomarkers of adiposity and sarcopenia as potential predictors for overall survival among patients with endometrial cancer treated with bevacizumab. Gynecol Oncol Rep. 2019 Nov; 30:100502. Gillen J, Mills KA, Dvorak J, Zheng B, Thai T, Salani R, Cosgrove CM, Davidson B, Thaker PH, Moore KN. PMID: 31720357; PMCID: PMC6838799.
      View in: PubMed   Mentions: 2  
    53. The Impact of Burnout on the Obstetrics and Gynecology Workforce. Clin Obstet Gynecol. 2019 09; 62(3):444-454. Vetter MH, Salani R, Williams TE, Ellison C, Satiani B. PMID: 31008731.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    54. Intentional weight loss, weight cycling, and endometrial cancer risk: a systematic review and meta-analysis. Int J Gynecol Cancer. 2019 11; 29(9):1361-1371. Zhang X, Rhoades J, Caan BJ, Cohn DE, Salani R, Noria S, Suarez AA, Paskett ED, Felix AS. PMID: 31451560; PMCID: PMC6832748.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    55. Measurements of adiposity as prognostic biomarkers for survival with anti-angiogenic treatment in epithelial ovarian cancer: An NRG Oncology/Gynecologic Oncology Group ancillary data analysis of GOG 218. Gynecol Oncol. 2019 10; 155(1):69-74. Wade KNS, Brady MF, Thai T, Wang Y, Zheng B, Salani R, Tewari KS, Gray HJ, Bakkum-Gamez JN, Burger RA, Moore KN, Bookman MA. PMID: 31409486; PMCID: PMC7048388.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    56. Preoperative predictors of endometrial cancer at time of hysterectomy for endometrial intraepithelial neoplasia or complex atypical hyperplasia. Am J Obstet Gynecol. 2020 01; 222(1):60.e1-60.e7. Vetter MH, Smith B, Benedict J, Hade EM, Bixel K, Copeland LJ, Cohn DE, Fowler JM, O'Malley D, Salani R, Backes FJ. PMID: 31401259; PMCID: PMC7201377.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    57. Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers. Br J Cancer. 2019 07; 121(2):180-192. Qian F, Rookus MA, Leslie G, Risch HA, Greene MH, Aalfs CM, Adank MA, Adlard J, Agnarsson BA, Ahmed M, Aittomäki K, Andrulis IL, Arnold N, Arun BK, Ausems MGEM, Azzollini J, Barrowdale D, Barwell J, Benitez J, Bialkowska K, Bonadona V, Borde J, Borg A, Bradbury AR, Brunet J, Buys SS, Caldés T, Caligo MA, Campbell I, Carter J, Chiquette J, Chung WK, Claes KBM, Collée JM, Collonge-Rame MA, Couch FJ, Daly MB, Delnatte C, Diez O, Domchek SM, Dorfling CM, Eason J, Easton DF, Eeles R, Engel C, Evans DG, Faivre L, Feliubadaló L, Foretova L, Friedman E, Frost D, Ganz PA, Garber J, Garcia-Barberan V, Gehrig A, Glendon G, Godwin AK, Gómez Garcia EB, Hamann U, Hauke J, Hopper JL, Hulick PJ, Imyanitov EN, Isaacs C, Izatt L, Jakubowska A, Janavicius R, John EM, Karlan BY, Kets CM, Laitman Y, Lázaro C, Leroux D, Lester J, Lesueur F, Loud JT, Lubinski J, Lukomska A, McGuffog L, Mebirouk N, Meijers-Heijboer HEJ, Meindl A, Miller A, Montagna M, Mooij TM, Mouret-Fourme E, Nathanson KL, Nehoray B, Neuhausen SL, Nevanlinna H, Nielsen FC, Offit K, Olah E, Ong KR, Oosterwijk JC, Ottini L, Parsons MT, Peterlongo P, Pfeiler G, Pradhan N, Radice P, Ramus SJ, Rantala J, Rennert G, Robson M, Rodriguez GC, Salani R, Scheuner MT, Schmutzler RK, Shah PD, Side LE, Simard J, Singer CF, Steinemann D, Stoppa-Lyonnet D, Tan YY, Teixeira MR, Terry MB, Thomassen M, Tischkowitz M, Tognazzo S, Toland AE, Tung N, van Asperen CJ, van Engelen K, van Rensburg EJ, Venat-Bouvet L, Vierstraete J, Wagner G, Walker L, Weitzel JN, Yannoukakos D, KConFab Investigators, HEBON Investigators, GEMO Study Collaborators, EMBRACE Collaborators, Antoniou AC, Goldgar DE, Olopade OI, Chenevix-Trench G, Rebbeck TR, Huo D, CIMBA. PMID: 31213659; PMCID: PMC6738050.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    58. Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early Stage Endometrial Cancer. J Clin Oncol. 2019 07 20; 37(21):1810-1818. Randall ME, Filiaci V, McMeekin DS, von Gruenigen V, Huang H, Yashar CM, Mannel RS, Kim JW, Salani R, DiSilvestro PA, Burke JJ, Rutherford T, Spirtos NM, Terada K, Anderson PR, Brewster WR, Small W, Aghajanian CA, Miller DS. PMID: 30995174; PMCID: PMC6804858.
      View in: PubMed   Mentions: 102     Fields:    Translation:HumansCTClinical Trials
    59. Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739). Gynecol Oncol. 2019 06; 153(3):496-499. Backes FJ, Cohen D, Salani R, Cohn DE, O'Malley DM, Fanning E, Suarez AA, Fowler JM. PMID: 31230614.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    60. GOG 8020/210: Risk stratification of lymph node metastasis, disease progression and survival using single nucleotide polymorphisms in endometrial cancer: An NRG oncology/gynecologic oncology group study. Gynecol Oncol. 2019 05; 153(2):335-342. Brooks RA, Tritchler DS, Darcy KM, Lankes HA, Salani R, Sperduto P, Guntupalli S, DiSilvestro P, Kesterson J, Olawaiye AB, Moxley K, Waggoner S, Santin A, Rader JS, Kizer NT, Thaker PH, Powell MA, Mutch DG, Birrer MJ, Goodfellow PJ. PMID: 30827726; PMCID: PMC6486855.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    61. Conization pathologic features as a predictor of intermediate and high risk features on radical hysterectomy specimens in early stage cervical cancer. Gynecol Oncol. 2019 05; 153(2):255-258. Hutchcraft ML, Smith B, McLaughlin EM, Hade EM, Backes FJ, O'Malley DM, Cohn DE, Fowler JM, Copeland LJ, Salani R. PMID: 30718123.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    62. Nomogram for Predicting Individual Survival After Recurrence of Advanced-Stage, High-Grade Ovarian Carcinoma. Obstet Gynecol. 2019 02; 133(2):245-254. Rose PG, Java JJ, Salani R, Geller MA, Secord AA, Tewari KS, Bender DP, Mutch DG, Friedlander ML, Van Le L, Method MW, Hamilton CA, Lee RB, Wenham RM, Guntupalli SR, Markman M, Muggia FM, Armstrong DK, Bookman MA, Burger RA, Copeland LJ. PMID: 30633128; PMCID: PMC6551603.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    63. Bariatric surgery after failed conservative management in a morbidly obese patient with endometrial cancer. Gynecol Oncol Rep. 2019 Feb; 27:69-71. Montemorano L, Smrz SA, Jalilvand AD, Noria SF, Salani R. PMID: 30723763; PMCID: PMC6351354.
      View in: PubMed   Mentions:
    64. The association between histological subtype of a first primary endometrial cancer and second cancer risk. Int J Gynecol Cancer. 2019 02; 29(2):290-298. Rhoades J, Vetter MH, Fisher JL, Cohn DE, Salani R, Felix AS. PMID: 30718311; PMCID: PMC6504982.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    65. Surgical complexity score and role of laparoscopy in women with advanced ovarian cancer treated with neoadjuvant chemotherapy. Gynecol Oncol. 2019 03; 152(3):554-559. Davidson BA, Broadwater G, Crim A, Boccacio R, Bixel K, Backes F, Previs RA, Salinaro J, Salani R, Moore K, Secord AA. PMID: 30558972.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    66. Outpatient desensitization of patients with moderate (high-risk) to severe platinum hypersensitivity reactions. Gynecol Oncol. 2019 02; 152(2):316-321. Vetter MH, Khan A, Backes FJ, Bixel K, Cohn DE, Copeland LJ, Fowler JM, Salani R, Li Q, O'Malley DM. PMID: 30503265.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    67. Time to chemotherapy in ovarian cancer: Compliance with ovarian cancer quality indicators at a National Cancer Institute-designated Comprehensive Cancer Center. Gynecol Oncol. 2018 12; 151(3):501-505. ElNaggar AC, Hade EM, O'Malley DM, Liang MI, Copeland LJ, Fowler JM, Salani R, Backes FJ, Cohn DE. PMID: 30282591.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    68. Ovarian effects of radiation and cytotoxic chemotherapy damage. Best Pract Res Clin Obstet Gynaecol. 2019 Feb; 55:37-48. Cosgrove CM, Salani R. PMID: 30166215.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansPHPublic Health
    69. Quality of life, symptoms and care needs in patients with persistent or recurrent platinum-resistant ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2018 07; 150(1):119-126. von Gruenigen VE, Huang HQ, Cella D, Zevon M, LaChance JA, Walker JL, Salani R, Modesitt SC, Morris RT, Bradley WH, Boente MP, Wenzel L. PMID: 29778506; PMCID: PMC6874212.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    70. Time to consider integration of a formal robotic-assisted surgical training program into obstetrics/gynecology residency curricula. J Robot Surg. 2018 Sep; 12(3):517-521. Vetter MH, Palettas M, Hade E, Fowler J, Salani R. PMID: 29285654.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    71. Life after endometrial cancer: A systematic review of patient-reported outcomes. Gynecol Oncol. 2018 02; 148(2):403-413. Shisler R, Sinnott JA, Wang V, Hebert C, Salani R, Felix AS. PMID: 29150143.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    72. Genetic consultation embedded in a gynecologic oncology clinic improves compliance with guideline-based care. Gynecol Oncol. 2017 10; 147(1):110-114. Senter L, O'Malley DM, Backes FJ, Copeland LJ, Fowler JM, Salani R, Cohn DE. PMID: 28800943.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    73. Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survival. Gynecol Oncol. 2017 09; 146(3):588-595. Cosgrove CM, Cohn DE, Hampel H, Frankel WL, Jones D, McElroy JP, Suarez AA, Zhao W, Chen W, Salani R, Copeland LJ, O'Malley DM, Fowler JM, Yilmaz A, Chassen AS, Pearlman R, Goodfellow PJ, Backes FJ. PMID: 28709704; PMCID: PMC5601318.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells
    74. BRCA mutation in ovarian cancer: testing, implications and treatment considerations. Ther Adv Med Oncol. 2017 Aug; 9(8):519-531. Neff RT, Senter L, Salani R. PMID: 28794804; PMCID: PMC5524247.
      View in: PubMed   Mentions: 59  
    75. An update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncology (SGO) recommendations. Gynecol Oncol. 2017 07; 146(1):3-10. Salani R, Khanna N, Frimer M, Bristow RE, Chen LM. PMID: 28372871.
      View in: PubMed   Mentions: 88     Fields:    Translation:Humans
    76. A phase I trial of paclitaxel, cisplatin, and veliparib in the treatment of persistent or recurrent carcinoma of the cervix: an NRG Oncology Study (NCT#01281852). Ann Oncol. 2017 03 01; 28(3):505-511. Thaker PH, Salani R, Brady WE, Lankes HA, Cohn DE, Mutch DG, Mannel RS, Bell-McGuinn KM, Di Silvestro PA, Jelovac D, Carter JS, Duan W, Resnick KE, Dizon DS, Aghajanian C, Fracasso PM. PMID: 27998970; PMCID: PMC5815561.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCTClinical Trials
    77. Chemotherapy completion in elderly women with ovarian, primary peritoneal or fallopian tube cancer - An NRG oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2017 03; 144(3):459-467. von Gruenigen VE, Huang HQ, Beumer JH, Lankes HA, Tew W, Herzog T, Hurria A, Mannel RS, Rizack T, Landrum LM, Rose PG, Salani R, Bradley WH, Rutherford TJ, Higgins RV, Secord AA, Fleming G. PMID: 28089376; PMCID: PMC5570471.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    78. Less radical surgery for early-stage cervical cancer: Can conization specimens help identify patients at low risk for parametrial involvement? Gynecol Oncol. 2017 Feb; 144(2):290-293. Smith B, McCann GA, Phillips G, Backes FJ, O'Malley DM, Cohn DE, Fowler JM, Copeland LJ, Salani R. PMID: 27884514.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    79. Perioperative Outcomes for Laparotomy Compared to Robotic Surgical Staging of Endometrial Cancer in the Elderly: A Retrospective Cohort. Int J Gynecol Cancer. 2016 11; 26(9):1717-1721. Backes FJ, ElNaggar AC, Farrell MR, Brudie LA, Ahmad S, Salani R, Cohn DE, Holloway RW, Fowler JM, O'Malley DM. PMID: 27575633.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    80. Is age a prognostic biomarker for survival among women with locally advanced cervical cancer treated with chemoradiation? An NRG Oncology/Gynecologic Oncology Group ancillary data analysis. Gynecol Oncol. 2016 Nov; 143(2):294-301. Moore KN, Java JJ, Slaughter KN, Rose PG, Lanciano R, DiSilvestro PA, Thigpen JT, Lee YC, Tewari KS, Chino J, Seward SM, Miller DS, Salani R, Moore DH, Stehman FB. PMID: 27542967; PMCID: PMC5693242.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    81. Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2016 10 01; 34(28):3460-73. Wright AA, Bohlke K, Armstrong DK, Bookman MA, Cliby WA, Coleman RL, Dizon DS, Kash JJ, Meyer LA, Moore KN, Olawaiye AB, Oldham J, Salani R, Sparacio D, Tew WP, Vergote I, Edelson MI. PMID: 27502591; PMCID: PMC5512594.
      View in: PubMed   Mentions: 137     Fields:    Translation:Humans
    82. Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline. Gynecol Oncol. 2016 10; 143(1):3-15. Wright AA, Bohlke K, Armstrong DK, Bookman MA, Cliby WA, Coleman RL, Dizon DS, Kash JJ, Meyer LA, Moore KN, Olawaiye AB, Oldham J, Salani R, Sparacio D, Tew WP, Vergote I, Edelson MI. PMID: 27650684; PMCID: PMC5413203.
      View in: PubMed   Mentions: 90     Fields:    Translation:Humans
    83. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus. Breast Cancer Res. 2016 06 21; 18(1):64. Zeng C, Guo X, Long J, Kuchenbaecker KB, Droit A, Michailidou K, Ghoussaini M, Kar S, Freeman A, Hopper JL, Milne RL, Bolla MK, Wang Q, Dennis J, Agata S, Ahmed S, Aittomäki K, Andrulis IL, Anton-Culver H, Antonenkova NN, Arason A, Arndt V, Arun BK, Arver B, Bacot F, Barrowdale D, Baynes C, Beeghly-Fadiel A, Benitez J, Bermisheva M, Blomqvist C, Blot WJ, Bogdanova NV, Bojesen SE, Bonanni B, Borresen-Dale AL, Brand JS, Brauch H, Brennan P, Brenner H, Broeks A, Brüning T, Burwinkel B, Buys SS, Cai Q, Caldes T, Campbell I, Carpenter J, Chang-Claude J, Choi JY, Claes KB, Clarke C, Cox A, Cross SS, Czene K, Daly MB, de la Hoya M, De Leeneer K, Devilee P, Diez O, Domchek SM, Doody M, Dorfling CM, Dörk T, Dos-Santos-Silva I, Dumont M, Dwek M, Dworniczak B, Egan K, Eilber U, Einbeigi Z, Ejlertsen B, Ellis S, Frost D, Lalloo F, EMBRACE, Fasching PA, Figueroa J, Flyger H, Friedlander M, Friedman E, Gambino G, Gao YT, Garber J, García-Closas M, Gehrig A, Damiola F, Lesueur F, Mazoyer S, Stoppa-Lyonnet D, behalf of GEMO Study Collaborators, Giles GG, Godwin AK, Goldgar DE, González-Neira A, Greene MH, Guénel P, Haeberle L, Haiman CA, Hallberg E, Hamann U, Hansen TV, Hart S, Hartikainen JM, Hartman M, Hassan N, Healey S, Hogervorst FB, Verhoef S, HEBON, Hendricks CB, Hillemanns P, Hollestelle A, Hulick PJ, Hunter DJ, Imyanitov EN, Isaacs C, Ito H, Jakubowska A, Janavicius R, Jaworska-Bieniek K, Jensen UB, John EM, Joly Beauparlant C, Jones M, Kabisch M, Kang D, Karlan BY, Kauppila S, Kerin MJ, Khan S, Khusnutdinova E, Knight JA, Konstantopoulou I, Kraft P, Kwong A, Laitman Y, Lambrechts D, Lazaro C, Le Marchand L, Lee CN, Lee MH, Lester J, Li J, Liljegren A, Lindblom A, Lophatananon A, Lubinski J, Mai PL, Mannermaa A, Manoukian S, Margolin S, Marme F, Matsuo K, McGuffog L, Meindl A, Menegaux F, Montagna M, Muir K, Mulligan AM, Nathanson KL, Neuhausen SL, Nevanlinna H, Newcomb PA, Nord S, Nussbaum RL, Offit K, Olah E, Olopade OI, Olswold C, Osorio A, Papi L, Park-Simon TW, Paulsson-Karlsson Y, Peeters S, Peissel B, Peterlongo P, Peto J, Pfeiler G, Phelan CM, Presneau N, Radice P, Rahman N, Ramus SJ, Rashid MU, Rennert G, Rhiem K, Rudolph A, Salani R, Sangrajrang S, Sawyer EJ, Schmidt MK, Schmutzler RK, Schoemaker MJ, Schürmann P, Seynaeve C, Shen CY, Shrubsole MJ, Shu XO, Sigurdson A, Singer CF, Slager S, Soucy P, Southey M, Steinemann D, Swerdlow A, Szabo CI, Tchatchou S, Teixeira MR, Teo SH, Terry MB, Tessier DC, Teulé A, Thomassen M, Tihomirova L, Tischkowitz M, Toland AE, Tung N, Turnbull C, van den Ouweland AM, van Rensburg EJ, Ven den Berg D, Vijai J, Wang-Gohrke S, Weitzel JN, Whittemore AS, Winqvist R, Wong TY, Wu AH, Yannoukakos D, Yu JC, Pharoah PD, Hall P, Chenevix-Trench G, KConFab, AOCS Investigators, Dunning AM, Simard J, Couch FJ, Antoniou AC, Easton DF, Zheng W. PMID: 27459855; PMCID: PMC4962376.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCellsPHPublic Health
    84. Beyond Chemotherapy: An Overview and Review of Targeted Therapy in Cervical Cancer. Clin Ther. 2016 Mar; 38(3):449-58. Crafton SM, Salani R. PMID: 26926322.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    85. Survival outcomes of obese patients in type II endometrial cancer: Defining the prognostic impact of increasing BMI. Gynecol Oncol. 2016 Mar; 140(3):405-8. Billingsley CC, Cansino C, O'Malley DM, Cohn DE, Fowler JM, Copeland LJ, Backes FJ, Salani R. PMID: 26801939.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    86. A Prospective, Comparative Study for the Evaluation of Postoperative Pain and Quality of Recovery in Patients Undergoing Robotic Versus Open Hysterectomy for Staging of Endometrial Cancer. J Minim Invasive Gynecol. 2016 Mar-Apr; 23(3):429-34. Cohn DE, Castellon-Larios K, Huffman L, Salani R, Fowler JM, Copeland LJ, O'Malley DM, Backes FJ, Eisenhauer EL, Abdel-Rasoul M, Puente EG, Bergese SD. PMID: 26776677.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    87. Documentation of Pregnancy Risk Assessment and Pregnancy Among Women Presenting for Gynecologic Oncology Consultation. Int J Gynecol Cancer. 2016 Jan; 26(1):35-42. Crafton S, Nekkanti S, Lynch C, Cohn DE, Fowler JM, Copeland LJ, O'Malley DM, Salani R, Backes FJ, Eisenhauer EL. PMID: 26658364.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    88. Evaluation of the Hematologic Safety of Same Day Versus Standard Administration (24- to 72-Hour Delay) of Pegfilgrastim in Gynecology Oncology Patients Undergoing Cytotoxic Chemotherapy. Int J Gynecol Cancer. 2015 Sep; 25(7):1331-6. Billingsley CC, Jacobson SN, Crafton SM, Crim AK, Li Q, Hade EM, Cohn DE, Fowler JM, Copeland LJ, Salani R, Backes FJ, O'Malley DM. PMID: 26067861.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    89. Lifestyle and Weight Management Counseling in Uterine Cancer Survivors: A Study of the Uterine Cancer Action Network. Int J Gynecol Cancer. 2015 Sep; 25(7):1285-91. Tseng JH, Roche KL, Jernigan AM, Salani R, Bristow RE, Fader AN. PMID: 25966932.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    90. Robotic Hysterectomy for Endometrial Cancer in Obese Patients With Comorbidities: Evaluating Postoperative Complications. Int J Gynecol Cancer. 2015 Sep; 25(7):1271-6. Backes FJ, Rosen M, Liang M, McCann GA, Clements A, Cohn DE, O'Malley DM, Salani R, Fowler JM. PMID: 26017249.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    91. Incorporating resident/fellow training into a robotic surgery program. J Surg Oncol. 2015 Dec; 112(7):684-9. Vetter MH, Green I, Martino M, Fowler J, Salani R. PMID: 26289120.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    92. Setting the bar: compliance with ovarian cancer quality indicators at a National Cancer Institute-designated Comprehensive Cancer Center. Gynecol Oncol. 2015 Sep; 138(3):689-93. Liang MI, ElNaggar AC, Nekkanti S, O'Malley DM, Hade EM, Copeland LJ, Fowler JM, Salani R, Backes FJ, Cohn DE. PMID: 26216728.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    93. The Use of Transvaginal Ultrasound in Type II Endometrial Cancer. Int J Gynecol Cancer. 2015 Jun; 25(5):858-62. Billingsley CC, Kenne KA, Cansino CD, Backes FJ, Cohn DE, O'Malley DM, Copeland LJ, Fowler JM, Salani R. PMID: 25768078.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    94. Neoadjuvant chemotherapy vs primary debulking surgery for advanced ovarian cancer. What is the debate regarding the ideal treatment: approach? age? or cost? Am J Obstet Gynecol. 2015 Jun; 212(6):695-6. Salani R. PMID: 26042956.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    95. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Gynecol Oncol. 2016 05; 141(2):386-401. Ovarian Cancer Association Consortium, Breast Cancer Association Consortium, and Consortium of Modif, Hollestelle A, van der Baan FH, Berchuck A, Johnatty SE, Aben KK, Agnarsson BA, Aittomäki K, Alducci E, Andrulis IL, Anton-Culver H, Antonenkova NN, Antoniou AC, Apicella C, Arndt V, Arnold N, Arun BK, Arver B, Ashworth A, Australian Ovarian Cancer Study Group, Baglietto L, Balleine R, Bandera EV, Barrowdale D, Bean YT, Beckmann L, Beckmann MW, Benitez J, Berger A, Berger R, Beuselinck B, Bisogna M, Bjorge L, Blomqvist C, Bogdanova NV, Bojesen A, Bojesen SE, Bolla MK, Bonanni B, Brand JS, Brauch H, Breast Cancer Family Register, Brenner H, Brinton L, Brooks-Wilson A, Bruinsma F, Brunet J, Brüning T, Budzilowska A, Bunker CH, Burwinkel B, Butzow R, Buys SS, Caligo MA, Campbell I, Carter J, Chang-Claude J, Chanock SJ, Claes KBM, Collée JM, Cook LS, Couch FJ, Cox A, Cramer D, Cross SS, Cunningham JM, Cybulski C, Czene K, Damiola F, Dansonka-Mieszkowska A, Darabi H, de la Hoya M, deFazio A, Dennis J, Devilee P, Dicks EM, Diez O, Doherty JA, Domchek SM, Dorfling CM, Dörk T, Silva IDS, du Bois A, Dumont M, Dunning AM, Duran M, Easton DF, Eccles D, Edwards RP, Ehrencrona H, Ejlertsen B, Ekici AB, Ellis SD, EMBRACE, Engel C, Eriksson M, Fasching PA, Feliubadalo L, Figueroa J, Flesch-Janys D, Fletcher O, Fontaine A, Fortuzzi S, Fostira F, Fridley BL, Friebel T, Friedman E, Friel G, Frost D, Garber J, García-Closas M, Gayther SA, GEMO Study Collaborators, GENICA Network, Gentry-Maharaj A, Gerdes AM, Giles GG, Glasspool R, Glendon G, Godwin AK, Goodman MT, Gore M, Greene MH, Grip M, Gronwald J, Gschwantler Kaulich D, Guénel P, Guzman SR, Haeberle L, Haiman CA, Hall P, Halverson SL, Hamann U, Hansen TVO, Harter P, Hartikainen JM, Healey S, HEBON, Hein A, Heitz F, Henderson BE, Herzog J, T Hildebrandt MA, Høgdall CK, Høgdall E, Hogervorst FBL, Hopper JL, Humphreys K, Huzarski T, Imyanitov EN, Isaacs C, Jakubowska A, Janavicius R, Jaworska K, Jensen A, Jensen UB, Johnson N, Jukkola-Vuorinen A, Kabisch M, Karlan BY, Kataja V, Kauff N, KConFab Investigators, Kelemen LE, Kerin MJ, Kiemeney LA, Kjaer SK, Knight JA, Knol-Bout JP, Konstantopoulou I, Kosma VM, Krakstad C, Kristensen V, Kuchenbaecker KB, Kupryjanczyk J, Laitman Y, Lambrechts D, Lambrechts S, Larson MC, Lasa A, Laurent-Puig P, Lazaro C, Le ND, Le Marchand L, Leminen A, Lester J, Levine DA, Li J, Liang D, Lindblom A, Lindor N, Lissowska J, Long J, Lu KH, Lubinski J, Lundvall L, Lurie G, Mai PL, Mannermaa A, Margolin S, Mariette F, Marme F, Martens JWM, Massuger LFAG, Maugard C, Mazoyer S, McGuffog L, McGuire V, McLean C, McNeish I, Meindl A, Menegaux F, Menéndez P, Menkiszak J, Menon U, Mensenkamp AR, Miller N, Milne RL, Modugno F, Montagna M, Moysich KB, Müller H, Mulligan AM, Muranen TA, Narod SA, Nathanson KL, Ness RB, Neuhausen SL, Nevanlinna H, Neven P, Nielsen FC, Nielsen SF, Nordestgaard BG, Nussbaum RL, Odunsi K, Offit K, Olah E, Olopade OI, Olson JE, Olson SH, Oosterwijk JC, Orlow I, Orr N, Orsulic S, Osorio A, Ottini L, Paul J, Pearce CL, Pedersen IS, Peissel B, Pejovic T, Pelttari LM, Perkins J, Permuth-Wey J, Peterlongo P, Peto J, Phelan CM, Phillips KA, Piedmonte M, Pike MC, Platte R, Plisiecka-Halasa J, Poole EM, Poppe B, Pylkäs K, Radice P, Ramus SJ, Rebbeck TR, Reed MWR, Rennert G, Risch HA, Robson M, Rodriguez GC, Romero A, Rossing MA, Rothstein JH, Rudolph A, Runnebaum I, Salani R, Salvesen HB, Sawyer EJ, Schildkraut JM, Schmidt MK, Schmutzler RK, Schneeweiss A, Schoemaker MJ, Schrauder MG, Schumacher F, Schwaab I, Scuvera G, Sellers TA, Severi G, Seynaeve CM, Shah M, Shrubsole M, Siddiqui N, et al. PMID: 25940428; PMCID: PMC4630206.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    96. Long-term survival advantage and prognostic factors associated with intraperitoneal chemotherapy treatment in advanced ovarian cancer: a gynecologic oncology group study. J Clin Oncol. 2015 May 01; 33(13):1460-6. Tewari D, Java JJ, Salani R, Armstrong DK, Markman M, Herzog T, Monk BJ, Chan JK. PMID: 25800756; PMCID: PMC4404424.
      View in: PubMed   Mentions: 109     Fields:    Translation:Humans
    97. Predicting inpatient stay lasting 2 midnights or longer after robotic surgery for endometrial cancer. J Minim Invasive Gynecol. 2015 May-Jun; 22(4):583-9. Liang MI, Rosen MA, Rath KS, Hade EM, Clements AE, Backes FJ, Eisenhauer EL, Salani R, O'Malley DM, Fowler JM, Cohn DE. PMID: 25573182.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    98. Swelling among women who need education about leg lymphedema: a descriptive study of lymphedema in women undergoing surgery for endometrial cancer. Int J Gynecol Cancer. 2014 Oct; 24(8):1507-12. Salani R, Preston MM, Hade EM, Johns J, Fowler JM, Paskett EP, Katz ML. PMID: 25078342; PMCID: PMC4174725.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    99. Outpatient rapid 4-step desensitization for gynecologic oncology patients with mild to low-risk, moderate hypersensitivity reactions to carboplatin/cisplatin. Gynecol Oncol. 2014 Oct; 135(1):90-4. Li Q, Cohn D, Waller A, Backes F, Copeland L, Fowler J, Salani R, O'Malley D. PMID: 25110329.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    100. Does intra-operative radiation at the time of pelvic exenteration improve survival for patients with recurrent, previously irradiated cervical, vaginal, or vulvar cancer? Gynecol Oncol. 2014 Oct; 135(1):95-9. Backes FJ, Billingsley CC, Martin DD, Tierney BJ, Eisenhauer EL, Cohn DE, O'Malley DM, Salani R, Copeland LJ, Fowler JM. PMID: 25084510.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    101. Addressing psychosocial issues that impact women's health: proceedings of the 2014 Meeting of the North American Society for Psychosocial Obstetrics & Gynecology. Womens Health (Lond). 2014 Jul; 10(4):349-51. Salani R, Waddell V, Schaffir J. PMID: 25259896.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    102. A phase II study of gemcitabine, carboplatin and bevacizumab for the treatment of platinum-sensitive recurrent ovarian cancer. Gynecol Oncol. 2014 Aug; 134(2):262-6. Eisenhauer EL, Zanagnolo V, Cohn DE, Salani R, O'Malley DM, Sutton G, Callahan MJ, Cobb B, Fowler JM, Copeland LJ. PMID: 24910452.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    103. Training the next generation of robotic surgeons using guided mentorship: a randomized controlled trial. J Minim Invasive Gynecol. 2014 Nov-Dec; 21(6):1075-9. Liang MI, McCann GA, Rath KS, Backes FJ, Cansino C, Salani R. PMID: 24893325.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    104. Feasibility of interval cytoreduction following neoadjuvant chemotherapy with carboplatin, weekly paclitaxel, and bevacizumab for advanced ovarian cancer--a phase 1 study. Int J Gynecol Cancer. 2014 May; 24(4):682-6. Salani R, O'Malley DM, Copeland LJ, Cohn DE, Backes FJ, Fowler JM, Eisenhauer EL. PMID: 24651631.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    105. Reply: To PMID 24316272. Am J Obstet Gynecol. 2014 Jul; 211(1):83. Salani R, Billingsley CC, Crafton SM. PMID: 24530821.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    106. Cancer and pregnancy: an overview for obstetricians and gynecologists. Am J Obstet Gynecol. 2014 Jul; 211(1):7-14. Salani R, Billingsley CC, Crafton SM. PMID: 24316272.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    107. Reducing readmissions after robotic surgical management of endometrial cancer: a potential for improved quality care. Gynecol Oncol. 2013 Dec; 131(3):508-11. Liang MI, Rosen MA, Rath KS, Clements AE, Backes FJ, Eisenhauer EL, Salani R, O'Malley DM, Fowler JM, Cohn DE. PMID: 24096114.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    108. Breast and gynecologic cancer-related extremity lymphedema: a review of diagnostic modalities and management options. World J Surg Oncol. 2013 Sep 22; 11:237. Tiwari P, Coriddi M, Salani R, Povoski SP. PMID: 24053624; PMCID: PMC3852359.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    109. Should bevacizumab be continued after progression on bevacizumab in recurrent ovarian cancer? Int J Gynecol Cancer. 2013 Jun; 23(5):833-8. Backes FJ, Richardson DL, McCann GA, Smith B, Salani R, Eisenhauer EL, Fowler JM, Copeland LJ, Cohn DE, O'Malley DM. PMID: 23640292.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    110. Survivorship planning in gynecologic cancer patients. Gynecol Oncol. 2013 Aug; 130(2):389-97. Salani R. PMID: 23707666.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    111. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet. 2013 Apr; 45(4):371-84, 384e1-2. Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, Edwards SL, Pickett HA, Shen HC, Smart CE, Hillman KM, Mai PL, Lawrenson K, Stutz MD, Lu Y, Karevan R, Woods N, Johnston RL, French JD, Chen X, Weischer M, Nielsen SF, Maranian MJ, Ghoussaini M, Ahmed S, Baynes C, Bolla MK, Wang Q, Dennis J, McGuffog L, Barrowdale D, Lee A, Healey S, Lush M, Tessier DC, Vincent D, Bacot F, Australian Cancer Study, Australian Ovarian Cancer Study, Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Gene Environment Interaction and Breast Cancer (GENICA), Swedish Breast Cancer Study (SWE-BRCA), Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Epidemiological study of BRCA1 & BRCA2 Mutation Carriers (EMBRACE), Genetic Modifiers of Cancer Risk in BRCA1/2 Mutation Carriers (GEMO), Vergote I, Lambrechts S, Despierre E, Risch HA, González-Neira A, Rossing MA, Pita G, Doherty JA, Alvarez N, Larson MC, Fridley BL, Schoof N, Chang-Claude J, Cicek MS, Peto J, Kalli KR, Broeks A, Armasu SM, Schmidt MK, Braaf LM, Winterhoff B, Nevanlinna H, Konecny GE, Lambrechts D, Rogmann L, Guénel P, Teoman A, Milne RL, Garcia JJ, Cox A, Shridhar V, Burwinkel B, Marme F, Hein R, Sawyer EJ, Haiman CA, Wang-Gohrke S, Andrulis IL, Moysich KB, Hopper JL, Odunsi K, Lindblom A, Giles GG, Brenner H, Simard J, Lurie G, Fasching PA, Carney ME, Radice P, Wilkens LR, Swerdlow A, Goodman MT, Brauch H, Garcia-Closas M, Hillemanns P, Winqvist R, Dürst M, Devilee P, Runnebaum I, Jakubowska A, Lubinski J, Mannermaa A, Butzow R, Bogdanova NV, Dörk T, Pelttari LM, Zheng W, Leminen A, Anton-Culver H, Bunker CH, Kristensen V, Ness RB, Muir K, Edwards R, Meindl A, Heitz F, Matsuo K, du Bois A, Wu AH, Harter P, Teo SH, Schwaab I, Shu XO, Blot W, Hosono S, Kang D, Nakanishi T, Hartman M, Yatabe Y, Hamann U, Karlan BY, Sangrajrang S, Kjaer SK, Gaborieau V, Jensen A, Eccles D, Høgdall E, Shen CY, Brown J, Woo YL, Shah M, Azmi MA, Luben R, Omar SZ, Czene K, Vierkant RA, Nordestgaard BG, Flyger H, Vachon C, Olson JE, Wang X, Levine DA, Rudolph A, Weber RP, Flesch-Janys D, Iversen E, Nickels S, Schildkraut JM, Silva Idos S, Cramer DW, Gibson L, Terry KL, Fletcher O, Vitonis AF, van der Schoot CE, Poole EM, Hogervorst FB, Tworoger SS, Liu J, Bandera EV, Li J, Olson SH, Humphreys K, Orlow I, Blomqvist C, Rodriguez-Rodriguez L, Aittomäki K, Salvesen HB, Muranen TA, Wik E, Brouwers B, Krakstad C, Wauters E, Halle MK, Wildiers H, Kiemeney LA, Mulot C, Aben KK, Laurent-Puig P, Altena AM, Truong T, Massuger LF, Benitez J, Pejovic T, Perez JI, Hoatlin M, Zamora MP, Cook LS, Balasubramanian SP, Kelemen LE, Schneeweiss A, Le ND, Sohn C, Brooks-Wilson A, Tomlinson I, Kerin MJ, Miller N, Cybulski C, Henderson BE, Menkiszak J, Schumacher F, Wentzensen N, Le Marchand L, Yang HP, Mulligan AM, Glendon G, Engelholm SA, Knight JA, Høgdall CK, Apicella C, Gore M, Tsimiklis H, Song H, Southey MC, Jager A, den Ouweland AM, Brown R, Martens JW, Flanagan JM, Kriege M, Paul J, Margolin S, Siddiqui N, Severi G, Whittemore AS, Baglietto L, McGuire V, Stegmaier C, Sieh W, Müller H, Arndt V, Labrèche F, Gao YT, Goldberg MS, Yang G, Dumont M, McLaughlin JR, Hartmann A, Ekici AB, Beckmann MW, Phelan CM, Lux MP, Permuth-Wey J, Peissel B, Sellers TA, Ficarazzi F, Barile M, Ziogas A, Ashworth A, Gentry-Maharaj A, Jones M, Ramus SJ, Orr N, Menon U, Pearce CL, Brüning T, Pike MC, Ko YD, Lissowska J, Figueroa J, Kupryjanczyk J, Chanock SJ, et al. PMID: 23535731; PMCID: PMC3670748.
      View in: PubMed   Mentions: 332     Fields:    Translation:HumansCells
    112. Do survivorship care plans impact patients' evaluations of care? A randomized evaluation with gynecologic oncology patients. Gynecol Oncol. 2013 Jun; 129(3):554-8. Brothers BM, Easley A, Salani R, Andersen BL. PMID: 23474344; PMCID: PMC3767310.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    113. Outcomes following percutaneous upper gastrointestinal decompressive tube placement for malignant bowel obstruction in ovarian cancer. Gynecol Oncol. 2013 Apr; 129(1):103-6. Rath KS, Loseth D, Muscarella P, Phillips GS, Fowler JM, O'Malley DM, Cohn DE, Copeland LJ, Eisenhauer EL, Salani R. PMID: 23369942; PMCID: PMC4098040.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    114. Neuroendocrine carcinoma of the uterine cervix: the role of multimodality therapy in early-stage disease. Gynecol Oncol. 2013 Apr; 129(1):135-9. McCann GA, Boutsicaris CE, Preston MM, Backes FJ, Eisenhauer EL, Fowler JM, Cohn DE, Copeland LJ, Salani R, O'Malley DM. PMID: 23357610.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    115. The impact of close surgical margins after radical hysterectomy for early-stage cervical cancer. Gynecol Oncol. 2013 Jan; 128(1):44-48. McCann GA, Taege SK, Boutsicaris CE, Phillips GS, Eisenhauer EL, Fowler JM, O'Malley DM, Copeland LJ, Cohn DE, Salani R. PMID: 23138134; PMCID: PMC4067461.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    116. Here it comes....the role of cost-effective analysis. Gynecol Oncol. 2012 Nov; 127(2):265-6. Salani R, O'Malley DM. PMID: 23062646.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    117. Pathogenesis and new therapeutic targets of ovarian cancer. J Oncol. 2012; 2012:867512. Shih IeM, Ho CM, Nakayama K, Salani R. PMID: 22969800; PMCID: PMC3437294.
      View in: PubMed   Mentions: 1  
    118. Recurrent ovarian cancer: is there a role for re-treatment with bevacizumab after an initial complete response to a bevacizumab-containing regimen? Gynecol Oncol. 2012 Nov; 127(2):362-6. McCann GA, Smith B, Backes FJ, Rath K, Chacko S, Salani R, Eisenhauer E, Fowler JM, Cohn DE, O'Malley DM. PMID: 22885866; PMCID: PMC3886294.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    119. Sexual function after intracavitary vaginal brachytherapy for early-stage endometrial carcinoma. Int J Gynecol Cancer. 2012 May; 22(4):703-8. Quick AM, Seamon LG, Abdel-Rasoul M, Salani R, Martin D. PMID: 22398710; PMCID: PMC3759987.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    120. Surgical management of epithelial ovarian cancer. Clin Obstet Gynecol. 2012 Mar; 55(1):75-95. Salani R, Bristow RE. PMID: 22343231.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    121. A phase I study of concurrent weekly topotecan and cisplatin chemotherapy with whole pelvic radiation therapy in locally advanced cervical cancer: a gynecologic oncology group study. Gynecol Oncol. 2012 Apr; 125(1):158-62. Rose PG, Sill MW, McMeekin DS, Ahmed A, Salani R, Yamada SD, Wolfson AH, Fusco N, Fracasso PM. PMID: 22198338; PMCID: PMC4533103.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    122. The impact of body weight on ovarian cancer outcomes. Int J Gynecol Cancer. 2011 Dec; 21(9):1601-5. Backes FJ, Nagel CI, Bussewitz E, Donner J, Hade E, Salani R. PMID: 21997171; PMCID: PMC4175395.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    123. Effect of chemotherapy delays and dose reductions on progression free and overall survival in the treatment of epithelial ovarian cancer. Gynecol Oncol. 2012 Feb; 124(2):221-4. Nagel CI, Backes FJ, Hade EM, Cohn DE, Eisenhauer EL, O'Malley DM, Fowler JM, Copeland LJ, Salani R. PMID: 22055764; PMCID: PMC4035808.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    124. Gynecologic care for breast cancer survivors: assisting in the transition to wellness. Am J Obstet Gynecol. 2012 May; 206(5):390-7. Salani R, Andersen BL. PMID: 22177185; PMCID: PMC3752900.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    125. Recurrence patterns and surveillance for patients with early stage endometrial cancer. Gynecol Oncol. 2011 Nov; 123(2):205-7. Salani R, Nagel CI, Drennen E, Bristow RE. PMID: 21820709.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    126. Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations. Am J Obstet Gynecol. 2011 Jun; 204(6):466-78. Salani R, Backes FJ, Fung MF, Holschneider CH, Parker LP, Bristow RE, Goff BA. PMID: 21752752.
      View in: PubMed   Mentions: 107     Fields:    Translation:HumansPHPublic Health
    127. Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancer. Gynecol Oncol. 2011 May 01; 121(2):269-72. O'Malley DM, Richardson DL, Rheaume PS, Salani R, Eisenhauer EL, McCann GA, Fowler JM, Copeland LJ, Cohn DE, Backes FJ. PMID: 21315428.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    128. The effect of age on the tolerability of intraperitoneal chemotherapy, complication rate, and survival in patients with ovarian cancer. Gynecol Oncol. 2010 Dec; 119(3):491-5. Kothari R, Nagel C, Koopmeiners JS, Ivy JJ, Geller M, Salani R, Argenta PA. PMID: 20888625.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    129. Patient-reported peripheral neuropathy of doxorubicin and cisplatin with and without paclitaxel in the treatment of advanced endometrial cancer: Results from GOG 184. Gynecol Oncol. 2010 Dec; 119(3):538-42. Cella D, Huang H, Homesley HD, Montag A, Salani R, De Geest K, Lee R, Spirtos NM. PMID: 20863554.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    130. Predictive value of endocervical curettage at cervical conization and provider practices in management of high-grade cervical dysplasia. J Reprod Med. 2010 Mar-Apr; 55(3-4):129-33. Barlin JN, Bristow RE, Murillo AM, Zahurak M, Veras E, Salani R. PMID: 20506673.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    131. Sustained progression-free survival with weekly paclitaxel and bevacizumab in recurrent ovarian cancer. Gynecol Oncol. 2009 Dec; 115(3):396-400. Hurt JD, Richardson DL, Seamon LG, Fowler JF, Copeland LJ, Cohn DE, Eisenhauer E, Salani R, O'Malley DM. PMID: 19804901.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    132. Proteomics-based approach to elucidate the mechanism of antitumor effect of curcumin in cervical cancer. Prostaglandins Leukot Essent Fatty Acids. 2009 Jan; 80(1):9-18. Madden K, Flowers L, Salani R, Horowitz I, Logan S, Kowalski K, Xie J, Mohammed SI. PMID: 19058955.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    133. Adenocarcinoma in situ of the uterine cervix: a metaanalysis of 1278 patients evaluating the predictive value of conization margin status. Am J Obstet Gynecol. 2009 Feb; 200(2):182.e1-5. Salani R, Puri I, Bristow RE. PMID: 19019325.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    134. Subdividing ovarian and peritoneal serous carcinoma into moderately differentiated and poorly differentiated does not have biologic validity based on molecular genetic and in vitro drug resistance data. Am J Surg Pathol. 2008 Nov; 32(11):1667-74. Vang R, Shih IeM, Salani R, Sugar E, Ayhan A, Kurman RJ. PMID: 18769340.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    135. Three case reports of laparoscopic management of granulosa cell tumor with intraoperative rupture and subsequent upstaging. J Minim Invasive Gynecol. 2008 Jul-Aug; 15(4):511-3. Salani R, Goodrich K, Song C, Grumbine FC. PMID: 18602055.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    136. Transverse colectomy in ovarian cancer surgical cytoreduction: operative technique and clinical outcome. Gynecol Oncol. 2008 Jun; 109(3):364-9. Bristow RE, Peiretti M, Zanagnolo V, Salani R, Giuntoli RL, Maggioni A. PMID: 18396322.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    137. Limited utility of conventional criteria for predicting unresectable disease in patients with advanced stage epithelial ovarian cancer. Gynecol Oncol. 2008 Feb; 108(2):271-5. Salani R, Axtell A, Gerardi M, Holschneider C, Bristow RE. PMID: 18164380.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    138. Annexin XI is associated with cisplatin resistance and related to tumor recurrence in ovarian cancer patients. Clin Cancer Res. 2007 Nov 15; 13(22 Pt 1):6842-9. Song J, Shih IeM, Salani R, Chan DW, Zhang Z. PMID: 17982121.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    139. Measurement of cyclin E genomic copy number and strand length in cell-free DNA distinguish malignant versus benign effusions. Clin Cancer Res. 2007 Oct 01; 13(19):5805-9. Salani R, Davidson B, Fiegl M, Marth C, Müller-Holzner E, Gastl G, Huang HY, Hsiao JC, Lin HS, Wang TL, Lin BL, Shih IeM. PMID: 17908972.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    140. Surgical management of mesenteric lymph node metastasis in patients undergoing rectosigmoid colectomy for locally advanced ovarian carcinoma. Ann Surg Oncol. 2007 Dec; 14(12):3552-7. Salani R, Diaz-Montes T, Giuntoli RL, Bristow RE. PMID: 17896149.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    141. Survival impact of multiple bowel resections in patients undergoing primary cytoreductive surgery for advanced ovarian cancer: a case-control study. Gynecol Oncol. 2007 Dec; 107(3):495-9. Salani R, Zahurak ML, Santillan A, Giuntoli RL, Bristow RE. PMID: 17854870.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    142. Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistance. Int J Gynecol Cancer. 2008 May-Jun; 18(3):487-91. Salani R, Kurman RJ, Giuntoli R, Gardner G, Bristow R, Wang TL, Shih IM. PMID: 17692090.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    143. Intraperitoneal cisplatin and paclitaxel versus intravenous carboplatin and paclitaxel chemotherapy for Stage III ovarian cancer: a cost-effectiveness analysis. Gynecol Oncol. 2007 Sep; 106(3):476-81. Bristow RE, Santillan A, Salani R, Diaz-Montes TP, Giuntoli RL, Meisner BC, Armstrong DK, Frick KD. PMID: 17688927.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    144. Amplicon profiles in ovarian serous carcinomas. Int J Cancer. 2007 Jun 15; 120(12):2613-7. Nakayama K, Nakayama N, Jinawath N, Salani R, Kurman RJ, Shih IeM, Wang TL. PMID: 17351921.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansCells
    145. Expression of extracellular matrix proteins in ovarian serous tumors. Int J Gynecol Pathol. 2007 Apr; 26(2):141-6. Salani R, Neuberger I, Kurman RJ, Bristow RE, Chang HW, Wang TL, Shih IeM. PMID: 17413980.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    146. Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: analysis of prognostic factors and survival outcome. Cancer. 2007 Feb 15; 109(4):685-91. Salani R, Santillan A, Zahurak ML, Giuntoli RL, Gardner GJ, Armstrong DK, Bristow RE. PMID: 17219441.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    147. Ovarian cancer specific kallikrein profile in effusions. Gynecol Oncol. 2007 May; 105(2):501-7. Shih IeM, Salani R, Fiegl M, Wang TL, Soosaipillai A, Marth C, Müller-Holzner E, Gastl G, Zhang Z, Diamandis EP. PMID: 17303231.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    148. A BTB/POZ protein, NAC-1, is related to tumor recurrence and is essential for tumor growth and survival. Proc Natl Acad Sci U S A. 2006 Dec 05; 103(49):18739-44. Nakayama K, Nakayama N, Davidson B, Sheu JJ, Jinawath N, Santillan A, Salani R, Bristow RE, Morin PJ, Kurman RJ, Wang TL, Shih IeM. PMID: 17130457; PMCID: PMC1693732.
      View in: PubMed   Mentions: 62     Fields:    Translation:HumansAnimalsCells
    149. Uterine torsion and fetal bradycardia associated with external cephalic version. Obstet Gynecol. 2006 Sep; 108(3 Pt 2):820-2. Salani R, Theiler RN, Lindsay M. PMID: 17018516.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    150. Digital karyotyping: an update of its applications in cancer. Mol Diagn Ther. 2006; 10(4):231-7. Salani R, Chang CL, Cope L, Wang TL. PMID: 16884326.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    Ritu's Networks
    Concepts (458)
    Derived automatically from this person's publications.
    _
    Co-Authors (30)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _